Ken Fisher Spectrum Pharmaceuticals Inc Transaction History

Fisher Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	BUY	$1.27 - $2.42 $618,900 - $1.18 Million	487,323 Added 842.03%	545,198 $692,000
Q3 2021 Oct 26, 2021	SELL	$2.15 - $3.82 $591 - $1,050	-275 Reduced 0.47%	57,875 $126,000
Q2 2021 Jul 27, 2021	BUY	$2.89 - $4.45 $867 - $1,335	300 Added 0.52%	58,150 $218,000
Q3 2020 Nov 10, 2020	SELL	$2.99 - $4.9 $84,030 - $137,709	-28,104 Reduced 32.7%	57,850 $236,000
Q2 2020 Aug 07, 2020	SELL	$2.11 - $3.38 $95,055 - $152,269	-45,050 Reduced 34.39%	85,954 $291,000
Q4 2019 Feb 12, 2020	SELL	$3.5 - $10.35 $245,910 - $727,191	-70,260 Reduced 34.91%	131,004 $477,000
Q2 2019 Jul 30, 2019	BUY	$7.36 - $11.26 $151,623 - $231,967	20,601 Added 11.4%	201,264 $1.73 Million
Q3 2018 Oct 24, 2018	BUY	$16.52 - $24.82 $461,932 - $694,016	27,962 Added 18.31%	180,663 $3.04 Million
Q2 2018 Jul 09, 2018	SELL	$14.31 - $21.75 $658,174 - $1 Million	-45,994 Reduced 23.15%	152,701 $3.2 Million
Q1 2018 May 11, 2018	SELL	$16.09 - $23.07 $1.37 Million - $1.97 Million	-85,386 Reduced 30.06%	198,695 $3.2 Million
Q1 2018 Apr 19, 2018	BUY	$16.09 - $23.07 $1.35 Million - $1.93 Million	83,829 Added 41.86%	284,081 $4.57 Million
Q4 2017 Jan 24, 2018	BUY	$13.36 - $20.73 $281,134 - $436,221	21,043 Added 11.74%	200,252 $3.8 Million
Q3 2017 Oct 17, 2017	BUY	$8.75 - $14.07 $1.57 Million - $2.52 Million	179,209	179,209 $2.52 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.